starting dose of retatrutide RETATRUTIDE: A Medication for Diabetes and Weight Loss Retatrutide 10 mg: vial guide

Visit frequency: First 3 months: every 24 weeks Maintenance phase: monthly or bi-monthly Each visit should include: Weight tracking Vitals and symptom check Adherence review Lab follow-up: Lipase for pancreatitis risk Kidney function for patients with hypertension or diabetes Thyroid function in at-risk patients Side effect protocols: Nausea, vomiting, diarrhea, and constipation should be managed with dietary advice, hydration plans, and OTC medications if appropriate

Matchett K, Wilson-Kanamori J, Portman J, Kapourani C, Fercoq F, May S et al

Int J Clin Pharmacol Therapeutics

People with cirrhosis or significant liver dysfunction should avoid supplements without hepatologist guidance

Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene

The drugs half-life is approximately 131 hours, supporting once-daily dosing